Biovail Launches Ralivia? To Canadian Physicians
Nov 7th 2007Drug InformationPain / Anesthetics
Biovail Corporation (NYSE:BVF)(TSX:BVF) announced that Ralivia?, the Company’s once-daily tramadol formulation, has been officially launched in Canada, and is now commercially available. Ralivia? is indicated for the management of pain of moderate severity in patients who require continuous treatment for several days or more. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
